Telix Pharmaceuticals Share Price Today
(NASDAQ: TLX)

Name: Telix Pharmaceuticals Share Price Today (NASDAQ: TLX) - Telix Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Telix Pharmaceuticals share price is $18.36 & ₹1,599.16 as on 4 Feb 2025, 2.30 'hrs' IST

$18.36

▲

-0.24

(-1.29%)

Market is closed - opens 8 PM, 04 Feb 2025

View live Telix Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Telix Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Telix Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Telix Pharmaceuticals share price movements

Today's Low: $18.01
Today's High: $18.63
$18.36
1.93%
Downside
Day's Volatility :3.33%
Upside
1.42%
52 Weeks Low: $14.01
52 Weeks High: $19.99
$18.36
23.69%
Downside
52 Weeks Volatility :29.91%
Upside
8.15%

Telix Pharmaceuticals (TLX) Returns

Period	Telix Pharmaceuticals Ltd	Index (Russel 2000)
3 Months	22.77%	0.0%
6 Months	22.77%	0.0%
1 Year	22.77%	0.0%
3 Years	22.77%	-11.2%

Telix Pharmaceuticals (TLX) Key Statistics

in dollars & INR

Previous Close	$18.6
Open	$18.25
Today's High	$18.625
Today's Low	$18.005
Market Capitalization	$5.2B
Today's Volume	$29.1K
52 Week High	$19.99
52 Week Low	$14.01
Revenue TTM	$645.7M
EBITDA	$73.1M
Earnings Per Share (EPS)	$0.09
PE Ratio	173.44
Profit Margin	7.62%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	20.49%

How to invest in Telix Pharmaceuticals Stock (TLX) from India?

It is very easy for Indian residents to invest directly in Telix Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Telix Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Telix Pharmaceuticals or TLX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Telix Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Telix Pharmaceuticals shares which would translate to 0.047 fractional shares of Telix Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Telix Pharmaceuticals, in just a few clicks!

Returns in Telix Pharmaceuticals (TLX) for Indian investors in Rupees

The Telix Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Telix Pharmaceuticals investment value today

Current value as on today

₹1,26,303

Returns

₹26,303

(+26.3%)

Returns from Telix Pharmaceuticals Stock

₹21,188 (+21.19%)

Dollar Returns

₹5,115 (+5.11%)

Indian investors sentiment towards Telix Pharmaceuticals (TLX)

-82%

Period: Jan 4, 2025 to Feb 3, 2025. Change in 30 Days versus previous period

Search interest for Telix Pharmaceuticals Stock from India on INDmoney has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Telix Pharmaceuticals

Analyst Forecast on Telix Pharmaceuticals Stock (TLX)

What analysts predicted

Upside of 9.95%

Target:

$20.19

Current:

$18.36

Insights on Telix Pharmaceuticals Stock (Ticker Symbol: TLX)

Price Movement
In the last 1 month, TLX stock has moved up by 24.6%

Telix Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Telix Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Telix Pharmaceuticals (TLX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Telix Pharmaceuticals Ltd	19.15%	22.77%	22.77%	22.77%	22.77%
Biontech Se	2.96%	55.69%	32.59%	-28.38%	275.86%
Regeneron Pharmaceuticals, Inc.	-6.04%	-36.88%	-28.13%	8.13%	72.63%
Vertex Pharmaceuticals Incorporated	14.71%	-2.66%	7.65%	89.79%	93.07%
Alnylam Pharmaceuticals, Inc.	16.37%	3.33%	58.94%	82.52%	122.46%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Telix Pharmaceuticals Ltd	173.44	173.44	NA	0.19	0.2	0.08	NA	1.21
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.89	16.89	1.06	44.96	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.15	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Telix Pharmaceuticals Ltd	NA	$5.2B	22.77%	173.44	7.62%
Biontech Se	Buy	$29.0B	275.86%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$75.1B	72.63%	16.89	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$112.9B	93.07%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.7B	122.46%	NA	-15.86%

About Telix Pharmaceuticals

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company offers Illuccix for the treatment of prostate cancer; and TLX66-CDx for the treatment of imaging osteomyelitis. Its products candidates include TLX591, a radio antibody-drug conjugate for the treatment of prostate cancer; TLX250-CDx for the treatment and diagnosis of renal (kidney) cancer; TLX101-CDx for brain (glioma) cancer; TLX66-CDx to treat bone marrow conditioning; TLX300-CDx for the treatment and diagnosis of soft tissue sarcoma; and TLX250 for the treatment of clear cell renal cell carcinoma. The company also develops TLX101 for the treatment of glioblastoma (brain cancer); TLX66 for the treatment of bone marrow conditioning; TLX300 for the treatment of soft tissue sarcoma; and TLX592, a prostate cancer therapy candidate for targeted alpha therapy. Telix Pharmaceuticals Limited was founded in 2015 and is headquartered in North Melbourne, Australia.

Organization	Telix Pharmaceuticals
Employees	0
CEO	Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA
Industry	Miscellaneous

Management People of Telix Pharmaceuticals

Name	Title
Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA	Co-Founder, MD, Group CEO & Executive Director
Mr. Darren Smith B.Bus., FCPA, M.B.A.	Group Chief Financial Officer
Dr. Andreas Kluge M.D., Ph.D.	Chief Medical Advisor
Dr. David N. Cade M.B.A., M.D., MBBS	Group Chief Medical Officer
Mr. Richard Valeix M.B.A.	Chief Executive Officer of Telix Therapeutics
Mr. Darren Patti	Group Chief Operating Officer
Dr. Michael Wheatcroft B.Sc., BSc(Hons), Ph.D., Ph.D., (Cantab)	Chief Scientist
Mr. Craig Ulrick	Chief Information Officer
Ms. Kyahn Williamson B.A.	Senior Vice President of Corporate Communications & Investor Relations
Ms. Lena Moran-Adams L.L.B.	Group General Counsel

Important FAQs about investing in TLX Stock from India :

What is Telix Pharmaceuticals share price today?

Telix Pharmaceuticals share price today stands at $18.36, Open: $18.25 ; Previous Close: $18.60 ; High: $18.63 ; Low: $18.01 ; 52 Week High: $19.99 ; 52 Week Low: $14.01.

The stock opens at $18.25, after a previous close of $18.60. The stock reached a daily high of $18.63 and a low of $18.01, with a 52-week high of $19.99 and a 52-week low of $14.01.

Can Indians buy Telix Pharmaceuticals shares?

Yes, Indians can invest in the Telix Pharmaceuticals (TLX) from India.

With INDmoney, you can buy Telix Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Telix Pharmaceuticals at zero transaction cost.

How can I buy Telix Pharmaceuticals shares from India?

It is very easy to buy Telix Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Telix Pharmaceuticals (TLX) be purchased?

Yes, you can buy fractional shares of Telix Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Telix Pharmaceuticals stocks?

To start investing in Telix Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.